Penn State College of Engineering

Battling disease with ultraviolet light

Architectural engineering faculty receive seed funds to study optical radiation disinfection
27-May-2020 1:25 PM EDT, by Penn State College of Engineering

Newswise — UNIVERSITY PARK, Pa. — Now and in the months to come, hospitals and commercial buildings will be tasked with sanitizing large indoor environments to prevent the transmission of viruses like SARS-CoV-2, which causes COVID-19. A new seed grant-funded study could provide the knowledge base needed to develop optical radiation products used in such large-scale sanitation processes.

William Bahnfleth, co-principal investigator (PI) and professor of architectural engineering at Penn State, is joining co-PI Suresh Kuchipudi, clinical professor of veterinary and biomedical sciences in Penn State’s College of Agricultural Sciences, to study the ability of optical radiation to disinfect surfaces and reduce transmission of viruses. 

Bahnfleth and his collaborators received approximately $90,000 in seed funds for the six-month project from Penn State’s Huck Institutes of the Life Sciences, College of Engineering and the Institutes of Energy and the Environment.

“Certain wavelengths of ultraviolet light have the ability to inactivate microorganisms, like fungi and viruses, by damaging their DNA or RNA so that they can no longer reproduce,” Bahnfleth said. “Our research question for this project asks how well different wavelengths work to deactivate, or kill, coronaviruses like COVID-19.” 

Inside a cabinet-like reactor, Bahnfleth, Kuchipudi and collaborator Jim Freihaut, professor of architectural engineering at Penn State, will measure the degree of disinfection of coronavirus samples exposed to ultraviolet light of 254- or 365-nanometer wavelengths for different time periods of exposure. The researchers will use a surrogate human coronavirus similar to the COVID-19 virus in their tests, which will be provided by the Penn State Department of Veterinary and Biomedical Sciences. The testing will take place in a Biosafety Level 2 laboratory at Penn State University Park. 

“When best-practice ultraviolet levels and exposure times are determined, ultraviolet-based disinfection devices can then be designed to deactivate airborne viruses in building air supply systems, room or equipment surfaces, facial masks and virus sampling equipment,” Freihaut said. “The same technology could be used, going forward, to also deactivate bacteria and other types of viruses, but the levels of ultraviolet light may need to be adjusted for each specific target contaminant.”

Ultimately, Freihaut said, stakeholders could apply those same capabilities in the HVAC systems of schools and conference rooms, which are significant hotbeds for the spread of flu viruses of all types. 

In the second segment of the project, Penn State’s Donghyun Rim, assistant professor of architectural engineering, and Richard Mistrick, associate professor of architectural engineering, will work with Bahnfleth to apply the findings of the experimental part of the study to computational fluid dynamics modeling and lighting simulations. The simulations will serve to predict the effect of the germicidal irradiation system combined with ventilation and filtration efforts on the viability of coronavirus samples. 

“We will develop a plan to control different elements that go into the spatial model, as well as the infection risk that moves around the air distribution space,” Rim said. “We also will model the typical air motion of a room, which is usually removed, cleaned and then recirculated in a space.” 

Merging the test data from the reactor system and the simulations, the researchers will then compare the ultraviolet sensitivity factors to those that have been reported in the literature for other virus types, like the polio-causing virus or the H1N1 flu virus, according to Freihaut. 

Bahnfleth emphasized the practical component of this study, or what will make it useful for future consumers and building developers. With successful findings, a lamp could be manufactured that has both germicidal and lighting elements, where the germicidal element could be switched off and on as easily as engaging a light switch.

“This is 100-year-old technology, but it has only had moderate penetration outside of specialized markets like health care,” Bahnfleth said. “However, many are now realizing it is a technology that has potential to protect people in many types of buildings from the SARS-CoV-2 virus that causes COVID-19 and other dangerous pathogens.”

Sez Atamturktur, Harry and Arlene Schell Professor and head of the Department of Architectural Engineering, emphasized how new research in architectural engineering – like what Bahnfleth, Freihaut, Rim and Mistrick are pursuing – is necessary to re-shape the future of building construction and design methods in the years to come.

“This research can serve to expedite the return back to shared building spaces like offices,” she said. 




Filters close

Showing results

110 of 2528
Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

access_time Embargo lifts in 2 days
Embargo will expire: 12-Jul-2020 7:00 PM EDT Released to reporters: 10-Jul-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jul-2020 7:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.


Showing results

110 of 2528

close
0.90636